PK5 fundamentals
An in-depth look to BASILEA PHARM.NA SF 1 operating, investing, and financing activities
PK5 free cash flow for H2 23 is -8.74 M EUR. For 2023, PK5 free cash flow was 14.45 M EUR and operating cash flow was 15.33 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM